Stop Foreign Drug Pricing

Help, Don’t Halt, the Development of COVID Cures

The Administration has proposed a dangerous new policy—known as Most Favored Nation pricing—that will hinder innovators developing cures and our country’s effort to reignite the economy.

This proposal is reckless and particularly right now it is irresponsible as researchers search for treatments and vaccines for COVID-19, which is being led by U.S. industry – the most innovative in the world.

Tell the White House: Keep fighting for cures. Drop the Most Favored Nation pricing proposal now.

 

Foreign Bureaucrats

 

Keep Focus on COVID-19 Treatments and Cures

In the middle of a nationwide effort that currently involves nearly 600 clinical trials in communities across all 50 U.S. states and the District of Columbia, U.S. bio-pharmaceutical innovators need to keep their focus on defeating COVID-19.

13 million Americans—one in every 25—are taking part in these trials, sponsored by government and industry and carried out by scientists, doctors, nurses, and caretakers at local universities, hospitals, and clinics in your community and throughout the United States. The approaches they are testing are available due to investments spanning decades.

 

COVID-19 CLINICAL TRIALS IN THE UNITED STATES

548
 
50

 

The interactive map will not load properly in this browser. Please visit this page with a modern browser. You can also download the data.

We need your help to tell the White House to drop the Most Favored Nation pricing proposal.

 

Act Now